Platelet Rich Plasma PRP
Plasma rich in growth factors or also known as platelet rich plasma (or its acronym PRGF / PRP), is a treatment within the framework of regenerative medicine, which has received a lot of attention in recent years.
Within our blood are red blood cells responsible for transporting oxygen from our lungs to all body tissues, in addition it also contains a number of elements involved in coagulation and wound healing called platelets. Within these platelets, and to lesser extent, outside them, in the serum, there are proteins called growth factors involved in a cascade of reactions that are activated when an injury occurs.
When a tissue is injured from trauma or a disease, our organism has the ability to heal and / or regenerate that tissue. Just like the process that takes place when a scar develops on our skin, we can cure an ulcer in the cornea, consolidate a fracture or cure the endothelium, the inner lining of our blood vessels.
With old age or injury or illnesses, our ability to regenerate can slow down or even stop and as a result of this osteoarthritis and degenerative diseases appear.
The ability to stimulate tissue and its ability to regenerate or simply accelerate this process is the aim when using treatments with plasma rich in growth factors.
Its application in injected liquid form, gel in surgeries, mixed with elements such as bone or cartilage, can promote and accelerate biological processes where without help the process is much slower.
Numerous studies support the accelerating effect and stimulation that plasma rich growth factors can have. These studies have been performed in tissues, in experimental models on specific tissues, such as skin, bone, cartilage, cornea or ligaments, and in animal models, in rabbits, sheep or rats in different structures, and ultimately in humans, in various studies both descriptive and clinical trials of high scientific evidence.
The main thing we must consider is how the platelet rich plasma is obtained in growth factors, as different processes get different types of plasma and therefore with different capabilities effectively.
The application of platelet rich plasma (PRP) has undergone substantial development since 1999, from the field of medicine and oral surgery to other specialties.
Its application to improve the sutures in reconstructions of heart arteries, the application in corneal ulcers, in delays and lack of bone healing are some examples of the breadth of fields where such therapy can be used.
The use of biological therapies should always be based on scientific evidence and several studies need to be performed prior to reaching the point where it can be applied in humans. Investigators at the Garcia Cugat Foundation have promoted various studies of tissues such as cartilage, tendons, ligaments and skin. These studies, as well as being the grounds for several doctoral theses have been published in journals of high scientific impact. Following many of these studies we have been able to develop human clinical studies which assess the effectiveness of plasma rich in growth factors in important areas such as cartilage lesions that lead to osteoarthritis or reconstruction of cruciate ligaments in the knee, a joint affected regularly in professional athletes internationally.
These treatments use a collection system that allows for the assured sterility of the plasma, with the handling performed in sterile areas of the hospital, permits complete traceability of the plasma obtained from extraction of the patient to its application both as outpatients and in the operating room during surgery.
Various surgeries have been improved with the use of plasma rich in growth factors because it has shown not only that it favors decreased inflammation in tissues but a faster recovery of the tissues where the therapy is applied. Decreased pain, faster regeneration and acceleration of many processes of recovery in these patients, not only in athletes who for obvious reasons require it but also in the general population that benefit from the comfort and reduced use of pharmaceutical drugs.